Global In-Vitro Inflammatory Bowel Disease (IBD) diagnostics market is growing rapidly because it has become increasingly common to find the cases of Crohn’s disease and ulcerative colitis worldwide. The major trends affecting this space are the introduction of new diagnostic techniques including non-invasive tests with better accuracy and patient comfort as well as increasing usage of point-of-care testing (POCT) solutions.
Additionally, molecular diagnostics such as polymerase chain reaction (PCR) and next-generation sequencing (NGS) are gaining popularity due to their potential to provide detailed information on genetic makeup and microbiome, which may facilitate personalized treatment approaches in these patients.
The IBD diagnostics market is booming with opportunities due to increased awareness on early disease diagnosis and emerging companion diagnostics aimed at personalizing treatment for individual patients. The introduction of artificial intelligence (AI) and machine learning (ML) into diagnostic instruments has added another dimension to data analysis and predictive diagnostics that allows better decision-making by healthcare providers. Additionally, rising healthcare costs in developing countries coupled with expanded health service delivery systems are creating growth chances for companies that want to extend their global presence.
The expanding global market for in-vitro diagnostics in the area of inflammatory bowel disease (IBD) is due to the rising cases of IBD, which consist of ulcerative colitis and Crohn’s disease. A long-term inflammation of the digestive tract, i.e. IBD, can decrease the quality of life for its victims. The symptoms exhibited by these diseases are complex, thereby making it hard to undertake diagnosis and treatment, hence requiring specific and speedy laboratory tests. IVDs play an important role in identifying IBDs, thereby monitoring disease progress as well as guiding therapeutic decisions.
Technological improvements have resulted in the creation of more exact and effective diagnostic tools including serological tests, genetic testing panels, and novel biomarker detection methods. Moreover, artificial intelligence and machine learning have enhanced diagnostic precision and forecasting capabilities leading to individualized treatment options for individuals with IBD.
While the market is presently dominated by North America and Europe, there are considerable development opportunities in Asia-Pacific, Latin America, and Middle East, which have emerged as a result of high IBD incidence rates, better access to health care services as well as investment in diagnostic technology. As such, it is expected that this market will be booming with benefits for patients and treatment of IBD.
| Attribute | Detail |
|---|---|
| Driver | Newer Biomarkers Offering in IBD Diagnostics |
The domain of inflammatory bowel disease (IBD) diagnosis is currently undergoing rapid changes owing to emerging biomarkers, which make for better disease identification and handling. Such developments are pertinent in dealing with the downsides associated with conventional diagnosis methods, especially invasive approaches like endoscopy. The rise in diagnostic technologies has also given rise to complex endoscopic and non-invasive modalities aimed at enhancing the comprehension of complications, more so, malignancies related to IBD.
To improve endoscopy’s effectiveness and lessen its burden on patients, innovative endoscopic methods including balloon-assisted endoscopy are being introduced alongside enhanced imaging methods. In order to understand the molecular epidemiology of IBD better, non-invasive biomarkers like genetic susceptibility factors and protein biomarkers are needed, which help in early diagnosis and individualized treatment plans. Some of the main bio-markers used to diagnose IBD include calprotectin, mucosal healing index, CReactive protein (CRP), and fecal immunochemical tests (FIT).
Predicted advancement in the future of IBD diagnostics entails that researchers will find molecular parameters that can be used for early detection and guiding therapy. The predictive disease course, reduction of invasive procedures, and facilitating disease monitoring will improve the management of IBD through incorporation of biomarkers in clinical practice. There are several key drivers for growth in the IBD diagnostics market, including identification and validation of novel biomarkers, which ongoing R&D has shown can radically change the way IBD is diagnosed and treated, with far-reaching implications for patients’ care.
The largest part of the worldwide In-vitro inflammatory bowel disease diagnostics market in the forecast period is projected to be made up of laboratory-based testing segment. Assays and biomarkers play a significant role in in-vitro IBD diagnostics that detect specific biomolecules associated with the diseases. Techniques such as ELISA, PCR, and immunochemistry are employed to identify biomarkers like C-reactive protein (CRP) or calprotectin and fecal occult blood. Growth of assays/biomarkers segment is propelled by advancements in fecal biomarkers like Calprotectin and Lactoferrin.
To meet the increasing needs for precise and effective diagnostic tools to detect and control IBD, there is a rising call for in-vitro IBD diagnostic assays and biomarkers. Major market players like DiaSorin S.p.A., F. Hoffmann-La Roche AG, and Siemens Healthineers AG are committed to coming up with new methods of assays and also biomarkers to enhance the diagnosis of IBD. It is anticipated that this segment, due to its importance in correctly identifying IBD, tracking disease progression, and informing treatment decisions, will dominate the global in-vitro IBD diagnostics market.
During the projected period, it is anticipated that the diagnostic laboratories segment will dominate the global in-vitro inflammatory bowel disease diagnostics market size. These laboratories are essential in diagnosing and managing IBD, including Crohn’s disease and ulcerative colitis. They also benefit from technological advances like high-throughput screening, molecular diagnostics or biomarker identification so that diagnostic laboratories can produce accurate and fast test results.
The rise in occurrence of IBD has resulted in the need for diagnostic testing, which diagnostic laboratories can fulfill. They have a variety of specialty tests, such as biomarkers and genetic testing, crucial for the diagnosis of IBD. Many diagnostic labs are part of extensive health care systems that allow easy access to diagnosis.
| Attrubute | Detail |
|---|---|
| Leading Region | North America region |
The North American area leads the in-vitro inflammatory bowel disease (IBD) diagnostics market. The region's high prevalence of IBD, modern healthcare infrastructure, and major expenditures in research and development activities for diagnostic technologies have all contributed to its leadership. Furthermore, the existence of important market participants and greater awareness of IBD diagnostics help to maintain North America's market dominance.
Leading market players are focusing on strategies such as new product launches, mergers, partnerships, and collaborations to strengthen their position.
F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott, SENTINEL Diagnostic, BTNX, Inc., Immundiagnostik AG, Quest Diagnostics, Sysmex SE, DiaSorin S.p.A, Biosystems S.A., Quidel Corporation, Eiken Chemical Co., Ltd. and the other players are following the latest in-vitro inflammatory bowel disease diagnostics market trends to avail lucrative revenue opportunities.
Prominent players have been profiled in the global in-vitro inflammatory bowel disease diagnostics market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and latest developments.
| Attribute | Detail |
|---|---|
| Market Value in 2023 | US$ 1.6 Bn |
| Market Forecast Value in 2034 | More than US$ 2.9 Bn |
| Growth Rate (CAGR) | 5.6% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2020 to 2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
| Competition Landscape | Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials |
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
The global in-vitro inflammatory bowel disease diagnostics market was worth US$ 1.6 Bn in 2023
The in-vitro inflammatory bowel disease diagnostics industry is projected to cross US$ 2.9 Bn by 2034
The CAGR of in-vitro inflammatory bowel disease diagnostics market is anticipated to be 5.6% from 2024 to 2034
Growth of the market is attributed to rise in prevalence of inflammatory bowel diseases (IBD) including ulcerative colitis and Crohn's disease. Increase in demand for less-invasive, resource-benefit, and cost-effective diagnostic modalities boosts market growth.
The assays/biomarker product segment accounted for major share in 2023
North America is expected to dominate the in-Vitro inflammatory bowel disease diagnostics market during the forecast period.
F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott, SENTINEL Diagnostic , BTNX, Inc., Immundiagnostik AG, Quest Diagnostics, Sysmex SE, DiaSorin S.p.A, Biosystems S.A., Quidel Corporation, Eiken Chemical Co., Ltd. and other prominent players
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global In-Vitro Inflammatory Bowel Disease Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecasts, 2020 - 2034
5. Key Insights
5.1. Key Product/Brand Analysis
5.2. Technological Outlook
5.3. Disease Prevalence and Incidence Rate of Colorectal Cancer in Europe
5.4. Overview: National Screening Program Scenario
5.5. Regulatory Scenario in Europe
6. Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecasts, By Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product, 2020 - 2034
6.3.1. Assays/Biomarker
6.3.1.1. Calprotectin
6.3.1.2. Lactoferrin
6.3.1.3. Bile Acids
6.3.1.4. H. pylori SA
6.3.1.5. Pancreatic Elastase
6.3.1.6. Others
6.3.2. Analyzers
6.4. Market Attractiveness By Product
7. Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecasts, By Testing Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Testing Type, 2020 - 2034
7.3.1. Laboratory-based Testing
7.3.2. Point-of-Care (POC) Testing
7.3.3. Self-testing Kits
7.4. Market Attractiveness By Testing Type
8. Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecasts, By End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By End-user, 2020 - 2034
8.3.1. Diagnostic Laboratories
8.3.2. Hospitals
8.3.3. Others (Homecare Testing & Research Institutes etc.)
8.4. Market Attractiveness By End-user
9. Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region
10. North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Product, 2020 - 2034
10.2.1. Assays/Biomarker
10.2.1.1. Calprotectin
10.2.1.2. Lactoferrin
10.2.1.3. Bile Acids
10.2.1.4. H. pylori SA
10.2.1.5. Pancreatic Elastase
10.2.1.6. Others
10.2.2. Analyzers
10.3. Market Value Forecast By Testing Type, 2020 - 2034
10.3.1. Laboratory-based Testing
10.3.2. Point-of-Care (POC) Testing
10.3.3. Self-testing Kits
10.4. Market Value Forecast By End-user, 2020 - 2034
10.4.1. Diagnostic Laboratories
10.4.2. Hospitals
10.4.3. Others (Homecare Testing & Research Institutes etc.)
10.5. Market Value Forecast By Country, 2020 - 2034
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Testing Type
10.6.3. By End-user
10.6.4. By Country
11. Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product, 2020 - 2034
11.2.1. Assays/Biomarker
11.2.1.1. Calprotectin
11.2.1.2. Lactoferrin
11.2.1.3. Bile Acids
11.2.1.4. H. pylori SA
11.2.1.5. Pancreatic Elastase
11.2.1.6. Others
11.2.2. Analyzers
11.3. Market Value Forecast By Testing Type, 2020 - 2034
11.3.1. Laboratory-based Testing
11.3.2. Point-of-Care (POC) Testing
11.3.3. Self-testing Kits
11.4. Market Value Forecast By End-user, 2020 - 2034
11.4.1. Diagnostic Laboratories
11.4.2. Hospitals
11.4.3. Others (Homecare Testing & Research Institutes etc.)
11.5. Market Value Forecast By Country, 2020 - 2034
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Testing Type
11.6.3. By End-user
11.6.4. By Country
12. Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product, 2020 - 2034
12.2.1. Assays/Biomarker
12.2.1.1. Calprotectin
12.2.1.2. Lactoferrin
12.2.1.3. Bile Acids
12.2.1.4. H. pylori SA
12.2.1.5. Pancreatic Elastase
12.2.1.6. Others
12.2.2. Analyzers
12.3. Market Value Forecast By Testing Type, 2020 - 2034
12.3.1. Laboratory-based Testing
12.3.2. Point-of-Care (POC) Testing
12.3.3. Self-testing Kits
12.4. Market Value Forecast By End-user, 2020 - 2034
12.4.1. Diagnostic Laboratories
12.4.2. Hospitals
12.4.3. Others (Homecare Testing & Research Institutes etc.)
12.5. Market Value Forecast By Country, 2020 - 2034
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Testing Type
12.6.3. By End-user
12.6.4. By Country
13. Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product, 2020 - 2034
13.2.1. Assays/Biomarker
13.2.1.1. Calprotectin
13.2.1.2. Lactoferrin
13.2.1.3. Bile Acids
13.2.1.4. H. pylori SA
13.2.1.5. Pancreatic Elastase
13.2.1.6. Others
13.2.2. Analyzers
13.3. Market Value Forecast By Testing Type, 2020 - 2034
13.3.1. Laboratory-based Testing
13.3.2. Point-of-Care (POC) Testing
13.3.3. Self-testing Kits
13.4. Market Value Forecast By End-user, 2020 - 2034
13.4.1. Diagnostic Laboratories
13.4.2. Hospitals
13.4.3. Others (Homecare Testing & Research Institutes etc.)
13.5. Market Value Forecast By Country, 2020 - 2034
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Testing Type
13.6.3. By End-user
13.6.4. By Country
14. Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Product, 2020 - 2034
14.2.1. Assays/Biomarker
14.2.1.1. Calprotectin
14.2.1.2. Lactoferrin
14.2.1.3. Bile Acids
14.2.1.4. H. pylori SA
14.2.1.5. Pancreatic Elastase
14.2.1.6. Others
14.2.2. Analyzers
14.3. Market Value Forecast By Testing Type, 2020 - 2034
14.3.1. Laboratory-based Testing
14.3.2. Point-of-Care (POC) Testing
14.3.3. Self-testing Kits
14.4. Market Value Forecast By End-user, 2020 - 2034
14.4.1. Diagnostic Laboratories
14.4.2. Hospitals
14.4.3. Others (Homecare Testing & Research Institutes etc.)
14.5. Market Value Forecast By Country, 2020 - 2034
14.5.1. GCC
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Testing Type
14.6.3. By End-user
14.6.4. By Country
15. Competition Landscape
15.1. Global Dental Bearings Market : Company Share Analysis (2023)
15.2. Company Profiles
15.2.1. F. Hoffmann-La Roche AG
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Product Portfolio
15.2.1.3. Financial Overview
15.2.1.4. SWOT Analysis
15.2.1.5. Strategic Overview
15.2.2. Thermo Fisher Scientific Inc.
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Product Portfolio
15.2.2.3. Financial Overview
15.2.2.4. SWOT Analysis
15.2.2.5. Strategic Overview
15.2.3. Abbott Laboratories
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Product Portfolio
15.2.3.3. Financial Overview
15.2.3.4. SWOT Analysis
15.2.3.5. Strategic Overview
15.2.4. Sentinel Diagnostic
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Product Portfolio
15.2.4.3. Financial Overview
15.2.4.4. SWOT Analysis
15.2.4.5. Strategic Overview
15.2.5. BTNX Inc.
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Product Portfolio
15.2.5.3. Financial Overview
15.2.5.4. SWOT Analysis
15.2.5.5. Strategic Overview
15.2.6. Immundiagnostik AG
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Product Portfolio
15.2.6.3. Financial Overview
15.2.6.4. SWOT Analysis
15.2.6.5. Strategic Overview
15.2.7. Quest Diagnostics
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Product Portfolio
15.2.7.3. Financial Overview
15.2.7.4. SWOT Analysis
15.2.7.5. Strategic Overview
15.2.8. Sysmex Europe SE
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Product Portfolio
15.2.8.3. Financial Overview
15.2.8.4. SWOT Analysis
15.2.8.5. Strategic Overview
15.2.9. Diasorin S.p.A
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Product Portfolio
15.2.9.3. Financial Overview
15.2.9.4. SWOT Analysis
15.2.9.5. Strategic Overview
15.2.10. BioSystems S.A.
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Product Portfolio
15.2.10.3. Financial Overview
15.2.10.4. SWOT Analysis
15.2.10.5. Strategic Overview
15.2.11. QuidelOrtho Corporation
15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.11.2. Product Portfolio
15.2.11.3. Financial Overview
15.2.11.4. SWOT Analysis
15.2.11.5. Strategic Overview
15.2.12. Other Prominent Players
15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.12.2. Product Portfolio
15.2.12.3. Financial Overview
15.2.12.4. SWOT Analysis
15.2.12.5. Strategic Overview
List of Tables
Table 01: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034
Table 02: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Assays/Biomarker, 2020-2034
Table 03: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Testing Type, 2020-2034
Table 04: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2020-2034
Table 05: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Region, 2020-2034
Table 06: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Country, 2020-2034
Table 07: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034
Table 08: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034
Table 09: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Testing Type, 2020-2034
Table 10: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2020-2034
Table 11: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 12: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034
Table 13: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034
Table 14: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Testing Type, 2020-2034
Table 15: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2020-2034
Table 16: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 17: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034
Table 18: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034
Table 19: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Testing Type, 2020-2034
Table 20: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2020-2034
Table 21: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034
Table 23: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034
Table 24: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Testing Type, 2020-2034
Table 25: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2020-2034
Table 26: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 27: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034
Table 28: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Product, 2020-2034
Table 29: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by Testing Type, 2020-2034
Table 30: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast, 2020-2034
Figure 02: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share, by Product, 2023
Figure 03: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share, by Testing Type, 2023
Figure 04: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share, by End-user, 2023
Figure 05: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034
Figure 06: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Share Analysis, by Product, 2023
Figure 07: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Share Analysis, by Product, 2034
Figure 08: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Product, 2024-2034
Figure 09: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn), by Assays/Biomarker, 2020‒2034
Figure 10: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Assays/Biomarker, 2024 and 2034
Figure 11: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn), by Analyzers, 2020‒2034
Figure 12: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Analyzers, 2024 and 2034
Figure 13: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Testing Type, 2023 and 2034
Figure 14: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Share Analysis, by Testing Type, 2023
Figure 15: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Share Analysis, by Testing Type, 2034
Figure 16: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Testing Type, 2024-2034
Figure 17: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn), by Clinical Testing Type, 2020‒2034
Figure 18: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Laboratory-based Testing, 2024 and 2034
Figure 19: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn), by Point-of-Care (POC) Testing, 2020‒2034
Figure 20: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Point-of-Care (POC) Testing, 2024 and 2034
Figure 21: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn), by Self-testing Kits, 2020‒2034
Figure 22: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Self-testing Kits, 2024 and 2034
Figure 23: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
Figure 24: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Share Analysis, by End-user, 2023
Figure 25: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Share Analysis, by End-user, 2034
Figure 26: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
Figure 27: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn), by Hospitals, 2020‒2034
Figure 28: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Hospitals, 2024 and 2034
Figure 29: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn), by Diagnostic Laboratories, 2020‒2034
Figure 30: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Diagnostic Laboratories, 2024 and 2034
Figure 31: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn), by Others, 2020‒2034
Figure 32: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Others, 2024 and 2034
Figure 33: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Region, 2023 and 2034
Figure 34: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Share Analysis, by Region, 2023
Figure 35: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Share Analysis, by Region, 2034
Figure 36: Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Region, 2024-2034
Figure 37: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 38: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Country, 2023 and 2034
Figure 39: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Country, 2024-2034
Figure 40: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034
Figure 41: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Product, 2024-2034
Figure 42: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Testing Type, 2023 and 2034
Figure 43: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Testing Type, 2024-2034
Figure 44: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
Figure 45: North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
Figure 46: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 47: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 49: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034
Figure 50: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Product, 2024-2034
Figure 51: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Testing Type, 2023 and 2034
Figure 52: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Testing Type, 2024-2034
Figure 53: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
Figure 54: Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
Figure 55: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 56: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 58: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034
Figure 59: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Product, 2024-2034
Figure 60: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Testing Type, 2023 and 2034
Figure 61: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Testing Type, 2024-2034
Figure 62: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
Figure 63: Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
Figure 64: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 65: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 66: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 67: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034
Figure 68: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Product, 2024-2034
Figure 69: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Testing Type, 2023 and 2034
Figure 70: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Testing Type, 2024-2034
Figure 71: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
Figure 72: Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
Figure 73: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 74: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 75: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 76: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Product, 2023 and 2034
Figure 77: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Product, 2024-2034
Figure 78: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by Testing Type, 2023 and 2034
Figure 79: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by Testing Type, 2024-2034
Figure 80: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
Figure 81: Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
In-vitro Inflammatory Bowel Disease Diagnostics Market
